Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A2P4LJ5
Thu, 11.09.2025
PharmaSGP Holding SE
PharmaSGP publishes preliminary half-year figures for 2025
Gräfelfing, September 11, 2025 – The German OTC pharmaceutical company PharmaSGP Holding SE generated revenues of €66.0 million in the first half of 2025 based on preliminary, unaudited figures. This corresponds to a 13.0% increase in revenues compared to the previous year (€58.4 million) [ … ]
Wed, 06.08.2025
PharmaSGP Holding SE
Ad-hoc announcement pursuant to Article 17 of the Regulation (EU) No. 596/2024
PharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchange effective upon the expiry of August 11, 2025
Gräfelfing, August 6, 2025 – The Management Board of PharmaSGP Holding SE (“PharmaSGP”) has been informed today about the decision of the man [ … ]
Mon, 28.07.2025
PharmaSGP Holding SE
PharmaSGP Holding SE publishes joint reasoned statement of the Management Board and Supervisory Board on the public delisting tender offer by FUTRUE GmbH
Gräfelfing, July 28, 2025 – The Management Board and Supervisory Board of PharmaSGP Holding SE (ISIN: DE000A2P4LJ5, WKN: A2P4LJ) today published their joint reasoned statement pursuant to Sectio [ … ]
Thu, 24.07.2025
PharmaSGP Holding SE
Ad-hoc announcement pursuant to Article 17 of the Regulation (EU) No. 596/2024
FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE
Gräfelfing, July 24, 2025 – FUTRUE GmbH informed PharmaSGP Holding SE (ISIN: DE000A2P4LJ5) today that it holds more than 95% of the shares in PharmaSGP Holding SE in [ … ]
Fri, 18.07.2025
PharmaSGP Holding SE
PharmaSGP Holding SE: Acceptance period for FUTRUE GmbH’s public delisting tender offer underway
Gräfelfing, July 18, 2025 – PharmaSGP Holding SE (ISIN: DE000A2P4LJ5 WKN: A2P4LJ) announces that the public delisting tender offer made by FUTRUE GmbH to the shareholders of PharmaSGP is open for acceptance.
Shareholders of PharmaSGP can tender their [ … ]
Fri, 11.07.2025
PharmaSGP Holding SE
Publication of inside information in accordance with Article 17 of Regulation (EU) No. 596/2014
PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025
Gräfelfing, July 11, 2025 – The Management Board of PharmaSGP Holding SE (ISIN: DE000A2P4LJ5) has today decided, based on an evaluation of current data on business development c [ … ]
Thu, 26.06.2025
PharmaSGP Holding SE
PharmaSGP Holding SE holds 2025 Annual General Meeting
91.12% of the registered share capital was represented
Minimum dividend of €0.05 per dividend-bearing share resolved
Management Board reports on successful operational development in 2024; forecast for current fiscal year 2025 confirmed
Gräfelfing, June 26, 2025 – German OTC pharmaceutical [ … ]
Wed, 18.06.2025
PharmaSGP Holding SE
PharmaSGP SE plans to redeem own shares – conditions for squeeze-out under conversion law are met
Gräfelfing, June 18, 2025 – PharmaSGP SE (ISIN: DE000A2P4LJ5) currently holds treasury shares representing approximately 4.06% of its share capital as a result of last year's share buyback. In order to make optimal use of the new authorization to acqu [ … ]
Tue, 10.06.2025
PharmaSGP Holding SE
Publication of inside information pursuant to Art. 17 para. 1 of
Regulation (EU) 596/2014
Ad-hoc Notification
PharmaSGP Holding SE: Conclusion of a delisting agreement and announcement of a delisting tender offer by FUTRUE GmbH
Gräfelfing, June 10, 2025. Today, PharmaSGP Holding SE (ISIN DE000A2P4LJ5 / WKN A2P4LJ) (“PharmaSGP”) entered into a [ … ]
Tue, 10.06.2025
Futrue GmbH
EQS-WpÜG: Futrue GmbH / Tender Offer
Tender Offer / Target company: Pharma SGP Holding SE; Bidder: Futrue GmbH
10.06.2025 / 08:35 CET/CEST
Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), transmitted by EQS News - a service of EQS Group.
The bidder is solely responsible for the cont [ … ]
